RCEL Q1 2026 Earnings EPS Misses Estimates Stock Gains Amid Operational Progress ACRV Q1 2026 Earnings NarrowerthanExpected Loss Provides Mild Upbeat Note Amid No Revenue FTAIM Q1 2026 Earnings Preferred Dividend Coverage in Focus After EPS Miss Fate Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss Amid Continued Pipeline Development DBX Q1 2026 Earnings EPS Beat Signals Resilience Despite Revenue Uncertainty CRGO Q1 2026 Earnings EPS Misses Estimates Stock Rallies on Broader Optimism BDCIW Holds Steady at 045 as Trading Range Consolidates Trinity Capital 7875 Notes TRINZ Hold Steady Near Par Amid Low Volatility Intellia Therapeutics NTLA Edges Higher Testing Resistance Near 1323 RZB Subordinated Debentures Hold Steady at 2529 Amid Stable Trading Rocket Companies RKT Edges Higher Approaching Resistance at 1496